Efficacy of Yeast beta-glucan on Alzheimer’s

Researchers found that yeast beta-glucan was related to a series of gut-brain axis events and can improve neuroinflammation and brain insulin resistance, which means that yeast beta-glucan may prevent Alzheimer’s

A recent study published by Angel Yeast Co., Ltd. on International Journal of Biological Macromolecules attracted much attention. Researchers found that yeast beta-glucan was related to a series of gut-brain axis events and can improve neuroinflammation and brain insulin resistance, which means that yeast beta-glucan may prevent Alzheimer’s disease. This study broadened the potential applications of yeast beta-glucan as a novel dietary supplement to prevent early-stage pathologies associated with AD.

Stronger biological activities

Yeast beta-glucan is a polysaccharide derived from Saccharomyces cerevisiae​, with featured molecular structure of a linear beta-(1, 3)-glucan backbone with beta-(1, 6)-linked side chains. It shows stronger biological activities than other sources of beta-glucans especially in immunity enhancing. “Nowadays, AD has become a global healthy problem, this study unveiled the relationship between yeast beta-glucan and AD, presenting a potential way to improve AD.” Said Poshy Zhang, R&D director of Angel Yeast Human Health Division.

 

If any questions about Yeast Betaglucan and the application guidance you can contact us via our website.

News item from VW-Ingredients
Share now:
Share on facebook
Share on twitter
Share on linkedin
Share on email

Request samples

Let us know which samples you would like to receive. Select your samples in our product list and click send.